Bavarian Nordic
Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-18
ACTIVE TRIALS6
PHASE 3 / 2-33
RECRUITING1
READOUTS ≤12 MONTHS2
READOUT SLIPPED >6 MO20%
Delay Index: of 5 active trials registered more than a year ago, 1 have moved their primary completion (readout) date by more than 6 months since first registration (median +0.0 months). See all sponsors →
Open Bavarian Nordic on the live radar map →| TRIAL | PHASE | STATUS | CONDITION | N | PRIMARY COMPLETION |
|---|---|---|---|---|---|
| MVA-BN NCT06549530 |
P2 | Active, not recruiting | Monkeypox (Mpox) | 460 | 2026-05-01 (+11 mo) |
| Jynneos NCT07199569 |
P2 | Active, not recruiting | Monkeypox (Mpox) | 970 | 2026-11-30 |
| MVA-BN-WEV NCT06899802 |
P2 | Active, not recruiting | Encephalitis | 411 | 2027-02 |
| CHIKV VLP vaccine booster NCT06007183 |
P3 | Active, not recruiting | Chikungunya Virus Infection | 715 | 2028-02 (-2 mo) |
| CHIKV VLP vaccine NCT07003984 |
P3 | Active, not recruiting | Chikungunya Virus | 720 | 2028-09 (-3 mo) |
| CHIKV VLP vaccine NCT07467707 |
P3 | Recruiting | Chikungunya Virus | 6144 | 2030-05 |